GSK plc/£GSK
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Ticker
£GSK
Sector
Primary listing
LSE
Employees
66,841
Headquarters
Website
GSK plc Metrics
BasicAdvanced
£83bn
14.96
£1.39
0.35
£0.66
3.18%
Price and volume
Market cap
£83bn
Beta
0.35
52-week high
£22.82
52-week low
£12.89
Average daily volume
8m
Dividend rate
£0.66
Financial strength
Current ratio
0.819
Quick ratio
0.504
Long term debt to equity
92.178
Total debt to equity
111.475
Dividend payout ratio (TTM)
44.86%
Interest coverage (TTM)
14.36%
Profitability
EBITDA (TTM)
11,335
Gross margin (TTM)
72.61%
Net profit margin (TTM)
17.50%
Operating margin (TTM)
28.92%
Effective tax rate (TTM)
15.02%
Revenue per employee (TTM)
£490,000
Management effectiveness
Return on assets (TTM)
9.78%
Return on equity (TTM)
43.31%
Valuation
Price to earnings (TTM)
14.957
Price to revenue (TTM)
2.574
Price to book
5.08
Price to tangible book (TTM)
-11.27
Price to free cash flow (TTM)
17.265
Free cash flow yield (TTM)
5.79%
Free cash flow per share (TTM)
1.202
Dividend yield (TTM)
3.18%
Growth
Revenue change (TTM)
4.11%
Earnings per share change (TTM)
123.15%
3-year revenue growth (CAGR)
3.66%
10-year revenue growth (CAGR)
3.16%
3-year earnings per share growth (CAGR)
-27.63%
10-year earnings per share growth (CAGR)
-4.30%
3-year dividend per share growth (CAGR)
2.52%
10-year dividend per share growth (CAGR)
-4.07%
What the Analysts think about GSK plc
Analyst ratings (Buy, Hold, Sell) for GSK plc stock.
GSK plc Financial Performance
Revenues and expenses
GSK plc Earnings Performance
Company profitability
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for GSK plc stock?
GSK plc (GSK) has a market cap of £83B as of April 23, 2026.
What is the P/E ratio for GSK plc stock?
The price to earnings (P/E) ratio for GSK plc (GSK) stock is 14.96 as of April 23, 2026.
Does GSK plc stock pay dividends?
Yes, the GSK plc (GSK) stock pays dividends to shareholders. As of April 23, 2026, the dividend rate is £0.66 and the yield is 3.18%. GSK plc has a payout ratio of 44.86% on a trailing twelve-month basis.
When is the next GSK plc dividend payment date?
The next GSK plc (GSK) dividend payment date is unconfirmed.
What is the beta indicator for GSK plc?
GSK plc (GSK) has a beta rating of 0.35. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.